Lecturer Biosketches & Disclosures
Philip M. Sherman, MD, FRCPC
Professor of Paediatrics, Microbiology, & Dentistry at the Hospital for Sick Children, University of Toronto , where he has been on faculty since 1984. Sherman completed medical school at the University of Calgary in 1977 and training in pediatrics at the University of California , San Francisco (1977-1980). Training in gastroenterology and research was completed at the Hospital for Sick Children in Toronto , Canada and the Walter Reed Army Institute of Research in Washington , DC (1980-1984). Sherman is the immediate Past-President of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition and a Past-President of the Canadian Association of Gastroenterology. He is the recipient of a Canada Research Chair (tier 1) in Gastrointestinal Disease (2001-2015). His research program is funded by support currently provided by the Crohn’s and Colitis Foundation of Canada and the Canadian Institutes of Health Research. Sherman serves on the Research Advisory Board of Antibe Therapeutics. His research interests focus on epithelial cell signal transduction responses to pathogenic, commensal and probiotic bacteria, and their products.
Disclosures:
Dr. Philip Sherman has a financial interest in Abbott Nutritionals, Antibe Therapeutics, AstraZeneca, InSinc Consultants, Institut Rosell-Lallemand Inc., Mead Johnson, Nestle Nutritional, and Proctor & Gamble.
Ekhard E. Ziegler, MD
Professor of Pediatrics, Director, Fomon Infant Nutrition Unit, Department of Pediatrics, University of Iowa, Iowa City, Iowa, USA. Dr. Ziegler received his medical education and pediatric training at the University of Innsbruck, Austria. He obtained training in infant nutrition under Dr. Samuel J. Fomon at the University of Iowa . Dr. Ziegler has conducted research on various aspects of nutrition of normal infants as well as premature infants. Areas of investigation included body composition of term infants and the growth of normal infants. Efforts to define the protein requirements of infants included a series of studies with formulas of varying protein content. Dr. Ziegler has a long-standing interest in the renal solute load of infant diets and has conducted several studies on cow milk-induced intestinal blood loss. With the use of stable isotopes he has studied zinc absorption and, more recently, the absorption and excretion of iron. In the area of the premature infant Dr. Ziegler's main concerns are meeting protein and iron requirements and improving the fortification of human milk. In collaboration with investigators at the University of Pennsylvania he has conducted a follow-up study of young adults who were fed soy formulas during infancy. He is currently studying methods for the prevention of vitamin D and iron deficiency in breastfed infants.
Disclosures:
Dr. Ekhard Ziegler receives grant/research support from Abbott Nutrition, Mead Johnson Nutrition, and Nestlé.
Josef Neu , MD
Professor of Pediatrics and Director of Neonatal/Perinatal Training at the University of Florida School of Medicine. Dr. Neu received his MD from the University of Wisconsin and served his residency in Pediatrics at Johns Hopkins Hospital and a Fellowship in Neonatal/Perinatal Medicine at Stanford University . He is also the current Chairman of the Council of the Organization of Neonatal Program Directors (CONTPD) and the Neonatology representative of the Council of Pediatric Subspecialties (CoPS). Dr. Neu’s primary interests are in the area of nutritional biochemistry and gastrointestinal development. He has established effective collaborative arrangements with researchers in the Departments of Pharmacology, Biochemistry, Analytical Chemistry, Chemical Engineering, Biophysics, Animal Sciences, and Biostatistics. Current research includes ongoing studies on 1) alterations in the intestinal microbiome and necrotizing enterocolitis and late- onset sepsis; 2) the intestinal microbiome and subsequent type 1 diabetes; 3) arginyl glutamine dipeptide and effects on retinopathy of prematurity; and 4) early nutritional alterations and long-term health.
Disclosures:
Dr. Josef Neu has nothing to disclose.